Parsons Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $25M | Sell |
99,302
-10,685
| -10% | -$2.3M | 1.13% | 17 |
|
|
2026
Q1 | $23.9M | Buy |
109,987
+24,096
| +28% | +$5.35M | 1.09% | 17 |
|
|
2025
Q4 | $19.6M | Buy |
85,891
+2,071
| +2% | +$472K | 1.08% | 18 |
|
|
2025
Q3 | $19.4M | Buy |
83,820
+577
| +0.7% | +$117K | 1.1% | 15 |
|
|
2025
Q2 | $15.5M | Sell |
83,243
-23,916
| -22% | -$4.44M | 0.95% | 18 |
|
|
2025
Q1 | $22.5M | Sell |
107,159
-4,231
| -4% | -$823K | 1.23% | 14 |
|
|
2024
Q4 | $19.8M | Buy |
111,390
+18,865
| +20% | +$3.47M | 1.07% | 17 |
|
|
2024
Q3 | $18.3M | Sell |
92,525
-285
| -0.3% | -$53.2K | 1.16% | 16 |
|
|
2024
Q2 | $15.9M | Sell |
92,810
-105
| -0.1% | -$17.4K | 1.08% | 17 |
|
|
2024
Q1 | $16.9M | Sell |
92,915
-798
| -0.9% | -$138K | 1.16% | 15 |
|
|
2023
Q4 | $14.5M | Buy |
93,713
+2,970
| +3% | +$433K | 1.04% | 17 |
|
|
2023
Q3 | $13.5M | Buy |
90,743
+132
| +0.1% | +$19.4K | 1.07% | 17 |
|
|
2023
Q2 | $12.2M | Buy |
90,611
+223
| +0.2% | +$32.7K | 0.93% | 18 |
|
|
2023
Q1 | $14.4M | Sell |
90,388
-3,086
| -3% | -$472K | 1.16% | 12 |
|
|
2022
Q4 | $15.1M | Buy |
93,474
+2,030
| +2% | +$311K | 1.26% | 12 |
|
|
2022
Q3 | $12.3M | Buy |
91,444
+12,779
| +16% | +$1.83M | 1.1% | 16 |
|
|
2022
Q2 | $12M | Sell |
78,665
-5,339
| -6% | -$816K | 1.08% | 15 |
|
|
2022
Q1 | $13.6M | Buy |
84,004
+1,105
| +1% | +$161K | 1.03% | 15 |
|
|
2021
Q4 | $11.2M | Buy |
82,899
+250
| +0.3% | +$29.5K | 0.8% | 23 |
|
|
2021
Q3 | $8.91M | Buy |
82,649
+2,546
| +3% | +$291K | 0.7% | 28 |
|
|
2021
Q2 | $9.02M | Buy |
80,103
+455
| +0.6% | +$51.2K | 0.69% | 30 |
|
|
2021
Q1 | $8.62M | Buy |
79,648
+5,712
| +8% | +$611K | 0.71% | 26 |
|
|
2020
Q4 | $7.92M | Buy |
73,936
+10,114
| +16% | +$972K | 0.68% | 28 |
|
|
2020
Q3 | $5.59M | Sell |
63,822
-520
| -0.8% | -$49K | 0.55% | 40 |
|
|
2020
Q2 | $6.32M | Buy |
64,342
+1,770
| +3% | +$156K | 0.67% | 34 |
|
|
2020
Q1 | $4.77M | Sell |
62,572
-9,255
| -13% | -$788K | 0.61% | 39 |
|
|
2019
Q4 | $6.36M | Sell |
71,827
-209
| -0.3% | -$17.4K | 0.64% | 35 |
|
|
2019
Q3 | $5.46M | Sell |
72,036
-2,515
| -3% | -$172K | 0.59% | 41 |
|
|
2019
Q2 | $5.42M | Sell |
74,551
-1,197
| -2% | -$94.1K | 0.59% | 39 |
|
|
2019
Q1 | $6.11M | Sell |
75,748
-3,525
| -4% | -$288K | 0.67% | 32 |
|
|
2018
Q4 | $7.31M | Sell |
79,273
-1,042
| -1% | -$91.6K | 0.9% | 24 |
|
|
2018
Q3 | $7.6M | Buy |
80,315
+113
| +0.1% | +$10.7K | 0.8% | 24 |
|
|
2018
Q2 | $7.43M | Sell |
80,202
-221
| -0.3% | -$21.6K | 0.84% | 23 |
|
|
2018
Q1 | $7.61M | Buy |
80,423
+285
| +0.4% | +$31.3K | 0.89% | 22 |
|
|
2017
Q4 | $7.75M | Sell |
80,138
-543
| -0.7% | -$51.2K | 0.86% | 21 |
|
|
2017
Q3 | $7.17M | Buy |
80,681
+1,163
| +1% | +$88.5K | 0.85% | 23 |
|
|
2017
Q2 | $5.77M | Sell |
79,518
-218
| -0.3% | -$14.7K | 0.7% | 32 |
|
|
2017
Q1 | $5.2M | Sell |
79,736
-431
| -0.5% | -$27.1K | 0.66% | 37 |
|
|
2016
Q4 | $5.02M | Buy |
80,167
+601
| +0.8% | +$36.7K | 0.67% | 37 |
|
|
2016
Q3 | $5.02M | Sell |
79,566
-463
| -0.6% | -$30K | 0.68% | 37 |
|
|
2016
Q2 | $4.96M | Sell |
80,029
-1,855
| -2% | -$113K | 0.67% | 39 |
|
|
2016
Q1 | $4.68M | Sell |
81,884
-241
| -0.3% | -$13.4K | 0.64% | 40 |
|
|
2015
Q4 | $4.87M | Buy |
82,125
+352
| +0.4% | +$20.3K | 0.68% | 38 |
|
|
2015
Q3 | $4.45M | Buy |
81,773
+310
| +0.4% | +$20.2K | 0.65% | 40 |
|
|
2015
Q2 | $5.47M | Buy |
81,463
+322
| +0.4% | +$21K | 0.73% | 27 |
|
|
2015
Q1 | $4.75M | Sell |
81,141
-19,443
| -19% | -$1.17M | 0.67% | 33 |
|
|
2014
Q4 | $6.58M | Sell |
100,584
-1,400
| -1% | -$88.3K | 0.87% | 21 |
|
|
2014
Q3 | $5.89M | Buy |
101,984
+545
| +0.5% | +$30.3K | 0.82% | 26 |
|
|
2014
Q2 | $5.72M | Sell |
101,439
-530
| -0.5% | -$27.8K | 0.79% | 26 |
|
|
2014
Q1 | $5.24M | Buy |
101,969
+16,281
| +19% | +$823K | 0.75% | 26 |
|
|
2013
Q4 | $4.53M | Sell |
85,688
-530
| -0.6% | -$26K | 0.68% | 38 |
|
|
2013
Q3 | $3.85M | Sell |
86,218
-14,238
| -14% | -$631K | 0.63% | 38 |
|
|
2013
Q2 | $4.15M | Buy |
+100,456
| New | +$4.39M | 0.71% | 33 |
|
Other funds holding ABBV
Parsons Capital Management's ABBV Position: Q2 2026 in Review
Parsons Capital Management reduced its AbbVie (ABBV) stake by 9.7% in Q2 2026, selling an estimated $2.3M and leaving 99,302 shares worth $25M. The position accounts for 1.13% of the portfolio, ranked #17.
Parsons Capital Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 2,841 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Parsons Capital Management held 99,302 shares of AbbVie worth $25M as of Q2 2026.
- Parsons Capital Management sold 10,685 AbbVie shares in Q2 2026, an estimated $2.3M.
- AbbVie made up 1.13% of Parsons Capital Management's portfolio in Q2 2026, its #17 holding.
- Parsons Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 2,841 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Parsons Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.